background objective patients stage iv cell lung cancer nsclc usually need radiotherapy good responses particularly brain bone metastases study evaluate influence radiotherapy survival stage iv nsclc patients methods clinical data NUMBER patients stage iv nsclc retrospectively analyzed brain treated parallel fields irradiation bone metastases treated local field irradiation primary tumors regional lymph nodes distant metastases treated conventional fractionation radiotherapy conformal radiotherapy brain bone radiotherapy delivered total dose NUMBER gy NUMBER fractions NUMBER weeks total dose NUMBER gy NUMBER fractions NUMBER weeks median dose primary tumors regional lymph nodes NUMBER gy gy median dose distant metastases NUMBER gy gy results median survival time NUMBER patients NUMBER months months overall survival rates NUMBER NUMBER median survival time significantly longer patients received chemotherapy patients didnt NUMBER months vs NUMBER months p NUMBER patients brain bone distant metastases median survival time NUMBER NUMBER NUMBER months respectively survival rates NUMBER NUMBER NUMBER respectively survival rates NUMBER NUMBER NUMBER respectively unitivariate analysis histological type patients age prognostic factors nsclc median survival time significantly longer adenocarcinoma patients squamous cell carcinoma patients carcinoma patients NUMBER months vs NUMBER NUMBER months p NUMBER longer patients NUMBER years old NUMBER years old NUMBER months vs NUMBER months p NUMBER longer patients bone metastases patients concomitant distant metastases NUMBER months vs NUMBER months p NUMBER significant difference patients brain metastases concomitant distant metastases NUMBER months vs NUMBER months p NUMBER radiotherapy primary tumors lymph nodes complications chronic diseases irradiation dose pattern effect survival conclusions histological type patients age affect efficacy radiotherapy stage iv nsclc irradiation patterns NUMBER gy NUMBER fractions NUMBER weeks NUMBER gy NUMBER fractions NUMBER weeks effect survival patients brain bone metastases non small NUMBER dimensional NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER year NUMBER year NUMBER year